Evaluation of KIR3DL1/KIR3DS1 allelic polymorphisms in Kenyan children with endemic Burkitt lymphoma
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0275046 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Beatrice M Muriuki und 8 weiteren Autor:innen. Beteiligte Einrichtung: West African Center for Cell Biology of Infectious Pathogens, College of Basic and Applied Sciences, University of Ghana, Accra, Ghana. Hauptthemen laut MEDLINE: Burkitt Lymphoma, Epstein-Barr Virus Infections, Malaria, Falciparum. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, NCI NIH HHS, US National Institute of Health, National Cancer Institute.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Endemic Burkitt lymphoma (eBL) is a fast-growing germinal center B cell lymphoma, affecting 5–10 per 100,000 children annually, in the equatorial belt of Africa. We hypothesize that co-infections with Plasmodium falciparum ( Pf ) malaria and Epstein-Barr virus (EBV) impair host natural killer (NK) and T cell responses to tumor cells, and thus increase the risk of eBL pathogenesis. NK cell education is partially controlled by killer immunoglobulin-like receptors and variable expression of KIR3DL1 has been associated with other malignancies. Here, we investigated whether KIR3D-mediated mechanisms contribute to eBL, by testing for an association of KIR3DL1 / KIR3DS1 genotypes with the disease in 108 eBL patients and 99 healthy Kenyan children. KIR3DL1 allelic typing and EBV loads were assessed by PCR. We inferred previously observed phenotypes from the genotypes. The frequencies of KIR3DL1 / KIR3DL1 and KIR3DL1 / KIR3DS1 did not differ significantly between cases and controls. Additionally, none of the study participants was homozygous for KIR3DS1 alleles. EBV loads did not differ by the KIR3DL1 genotypes nor were they different between eBL survivors and non-survivors. Our results suggest that eBL pathogenesis may not simply involve variations in KIR3DL1 and KIR3DS1 genotypes. However, considering the complexity of the KIR3DL1 locus, this study could not exclude a role for copy number variation in eBL pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- West African Center for Cell Biology of Infectious Pathogens, College of Basic and Applied Sciences, University of Ghana, Accra, Ghana.
- Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
- Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, United States of America.
- Department of Pathology and Laboratory Medicine, Warren Alpert Medical School, Brown University, Providence, RI, United States of America.
- Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon, Accra, Ghana.
ORCID-Profile: Beatrice M Muriuki, Anita Ghansah, John M Ong'echa
Förderung
- Wellcome Trust
- NCI NIH HHS
- US National Institute of Health, National Cancer Institute
- DELTAS Africa grant
Zitieren
APA
Muriuki, B. M., Forconi, C. S., Kirwa, E. K., Maina, T. K., Ariera, B. O., Bailey, J. A., Ghansah, A., Moormann, A. M., & Ong'echa, J. M. (2023). Evaluation of KIR3DL1/KIR3DS1 allelic polymorphisms in Kenyan children with endemic Burkitt lymphoma. PLOS ONE. https://doi.org/10.1371/journal.pone.0275046
Vancouver
Muriuki BM, Forconi CS, Kirwa EK, Maina TK, Ariera BO, Bailey JA, et al. Evaluation of KIR3DL1/KIR3DS1 allelic polymorphisms in Kenyan children with endemic Burkitt lymphoma. PLOS ONE. 2023. doi:10.1371/journal.pone.0275046
BibTeX
@article{Muriuki2023,
author = {Muriuki, Beatrice M and Forconi, Catherine S and Kirwa, Erastus K and Maina, Titus K and Ariera, Bonface O and Bailey, Jeffrey A and Ghansah, Anita and Moormann, Ann M and Ong'echa, John M},
title = {Evaluation of KIR3DL1/KIR3DS1 allelic polymorphisms in Kenyan children with endemic Burkitt lymphoma},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0275046}
}
EUVIMED